Jay J L, Murray S B
Tennent Institute of Ophthalmology, University of Glasgow, Western Infirmary, UK.
Br J Ophthalmol. 1988 Dec;72(12):881-9. doi: 10.1136/bjo.72.12.881.
The results of a randomised, prospective, multicentre trial of the management of primary open angle glaucoma are presented at up to five years' follow up. Previously undiagnosed cases were selected with intraocular pressure of 26 mmHg or more on two occasions together with field loss characteristic of glaucoma. Analysis was performed on one eye selected at random from each of 99 patients. Conventional medical treatment followed in unsuccessful cases by trabeculectomy (group A) was compared with trabeculectomy at diagnosis followed when necessary by supplementary medical therapy (group B). The life expectancy of these glaucoma patients was found to be similar to that for the local population matched for age and sex. In group A after four years trabeculectomy had been performed in 53% of eyes because medical management had failed to control the disease. The rate of operation was lower in those patients with intraocular pressure less than 31 mmHg and mild relative field loss (17% at three years) than in those with intraocular pressure greater than 30 mmHg and dense scotomas (75% at three years). Early surgery provided much more stable control with fewer changes in treatment than in group A. The group mean intraocular pressure after trabeculectomy was 15.0 mmHg irrespective of the time of operation, and this was significantly lower than the intraocular pressure in those cases thought to be controlled on medical therapy alone at the end of the first year (20.8 mmHg). Early operation provided significantly better protection of visual field, and the extra loss of visual field with delayed operation occurred in the preoperative period. Changes in visual fields were not related to the use of miotics. There was no significant difference in the final visual acuity in the two groups, but six cases in group A lost central fixation because of progressive loss of visual field, and there were no such cases in group B. Cataract occurred in approximately 10% of cases in both groups, but in group A this happened with only half the number of operations and at a shorter postoperative follow-up than in group B. It appears that in cases of primary open angle glaucoma of this severity the risk of delaying operation are significantly greater than those of performing trabeculectomy as the primary treatment.
本文呈现了一项关于原发性开角型青光眼治疗的随机、前瞻性、多中心试验的结果,随访时间长达五年。选取此前未被诊断出的病例,这些病例两次测量的眼压均为26毫米汞柱或更高,且伴有青光眼特征性的视野缺损。对99例患者中随机选取的一只眼睛进行分析。将常规药物治疗无效后行小梁切除术的患者(A组)与诊断时即行小梁切除术、必要时辅以药物治疗的患者(B组)进行比较。发现这些青光眼患者的预期寿命与年龄和性别匹配的当地人群相似。在A组中,四年后53%的眼睛因药物治疗未能控制病情而接受了小梁切除术。眼压低于31毫米汞柱且相对视野缺损较轻的患者手术率较低(三年时为17%),低于眼压高于30毫米汞柱且有密集暗点的患者(三年时为75%)。早期手术提供了更稳定的控制,与A组相比治疗变化更少。无论手术时间如何,小梁切除术后组平均眼压为15.0毫米汞柱,这显著低于那些在第一年结束时仅通过药物治疗被认为病情得到控制的病例的眼压(20.8毫米汞柱)。早期手术对视野的保护明显更好,延迟手术导致的额外视野损失发生在术前阶段。视野变化与使用缩瞳剂无关。两组最终视力无显著差异,但A组有6例因视野逐渐丧失而失去中心注视,B组无此类病例。两组中约10%的病例发生了白内障,但A组发生白内障时的手术次数仅为B组的一半,且术后随访时间比B组短。看来,对于这种严重程度的原发性开角型青光眼病例,延迟手术的风险明显大于将小梁切除术作为主要治疗方法的风险。